Question 1

Does Barclays own JANX stock?

Accepted Answer

Yes. As of its Q2 2026 13F, Barclays holds 63,679 shares of JANX (Janux Therapeutics), worth $978,110.

Question 2

How many shares of JANX does Barclays own?

Accepted Answer

As of its Q2 2026 13F, Barclays holds 63,679 shares of JANX (Janux Therapeutics).

Question 3

What is Barclays' JANX position worth?

Accepted Answer

As of its Q2 2026 13F, Barclays' JANX position is worth $978,110.

Question 4

Is Barclays buying or selling JANX?

Accepted Answer

In Q2 2026, Barclays increased its JANX position by 7,691 shares (+13.7%).

Question 5

When did Barclays first buy JANX?

Accepted Answer

Barclays first reported JANX in its Q1 2022 13F and has listed it in 18 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Increased	63,679	+13.7%	$978,110	0.0%	$15.36	28
2026-Q1	Decreased	55,988	-74.7%	$778,232	0.0%	$13.90	0
2025-Q4	Increased	221,233	+53.6%	$3.1M	0.0%	$13.80	37
2025-Q3	Increased	144,024	+8.8%	$3.5M	0.0%	$24.44	29
2025-Q2	Increased	132,341	+95.3%	$3.1M	0.0%	$23.10	42
2025-Q1	Decreased	67,766	-74.3%	$1.8M	0.0%	$27.00	0
2024-Q4	Increased	263,970	+51.6%	$14.1M	0.0%	$53.54	39
2024-Q3	Increased	174,061	+496.6%	$7.9M	0.0%	$46.25	44